Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WellSpan Cancer Institute is a leading provider of comprehensive oncology services in South Central Pennsylvania and Northern Maryland. As a division of the WellSpan Health system, the institute offers a multidisciplinary approach to cancer care, including medical oncology, radiation oncology, and surgical specialties. The institute is recognized for its clinical collaboration with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, which facilitates patient access to advanced research and complex treatment protocols. Facilities are equipped with state-of-the-art technology for diagnosis and treatment, such as advanced imaging and precision radiation therapy. Beyond clinical treatment, the institute provides extensive support services, including nurse navigation, genetic counseling, and survivorship programs. It is accredited by the American College of Surgeons Commission on Cancer, reflecting its commitment to high-quality, patient-centered care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WellSpan Cancer Institute.